Evidence map›Paper›PMID 42686932›Full record

ArticleMolecular imaging and biology2026

[

Francesco Fiz, Gianluca Bottoni, Monica Boitano, Martina Ugolini, Giulia Rosari, Giulia Magistrali, Michela Massollo, Massimiliano Iacozzi, Laura Tomasello, Fabio Campodonico and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Francesco FizDepartment of Nuclear Medicine, E.O. Ospedali Galliera, Mura Delle Cappuccine 14, 16128, Genoa, Italy.
Gianluca BottoniDepartment of Nuclear Medicine, E.O. Ospedali Galliera, Mura Delle Cappuccine 14, 16128, Genoa, Italy.
Monica BoitanoMedical Oncology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Martina UgoliniDepartment of Nuclear Medicine, E.O. Ospedali Galliera, Mura Delle Cappuccine 14, 16128, Genoa, Italy.
Giulia RosariIRCCS Fondazione Bietti, Monterotondo, Italy.
Giulia MagistraliPharmacology Unit, Galliera Hospital, Genoa, Italy.
Michela MassolloDepartment of Nuclear Medicine, E.O. Ospedali Galliera, Mura Delle Cappuccine 14, 16128, Genoa, Italy.
Massimiliano IacozziDepartment of Nuclear Medicine, E.O. Ospedali Galliera, Mura Delle Cappuccine 14, 16128, Genoa, Italy.
Laura TomaselloUrological Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Fabio CampodonicoUrological Unit, Galliera Hospital, Genoa, Italy.
Diego CecchinNuclear Medicine Unit, Department of Medicine (DIMED), University of Padova, Padua, Italy.
Carlo Luigi Augusto NegroUrological Unit, Ospedale Evangelico Internazionale, Genoa, Italy.
Stefano PanareoDepartment of Nuclear Medicine, Oncology and Hematology, University Hospital of Modena, Modena, Italy.
Luca TimossiUrological Unit, Ospedale Evangelico Internazionale, Genoa, Italy.
Giacomo VallomeMedical Oncology Unit, Ospedale Padre Antero Micone, ASL3, Genoa, Italy.
Giorgio TregliaFaculty of Biomedical Sciences, Università Della Svizzera Italiana (USI), Lugano, Switzerland.
Carlo IntroiniUrological Unit, Galliera Hospital, Genoa, Italy.
Arnoldo PiccardoDepartment of Nuclear Medicine, E.O. Ospedali Galliera, Mura Delle Cappuccine 14, 16128, Genoa, Italy. arnoldo.piccardo@galliera.it.ORCID http://orcid.org/0000-0003-3932-1330

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMuscle-invasive bladder cancer (miBC) is an aggressive malignancy that can be visualised with [ MATERIALS AND

methodsPatients with available [

resultsThirty patients (six women) were included. SUVmean of the primary (p < 0.05), as well as its SUVmax, volume, and TLC (p < 0.01), were higher in patients with disease progression and in those who died of disease. Whole-body tumour volume (p = 0.001) and the presence of metastases (p = 0.024) were independent predictors of PFS; whole-body tumour volume was the only parameter with borderline significance in the DSS model (p = 0.067). Patients progressing under chemotherapy had a higher whole-body tumour volume and TLC (p < 0.05) than those who didn't.

conclusions[

Indexed as

[64Cu]CuCl2Muscle-invasive bladder cancerPETPrognosis

Identifiers

PMID42686932

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.